Athira Pharma, Inc. (ATHA) Financials
ATHA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 160245 | 30057 |
2023-09-30 | 184.7 million | 29.9 million |
2023-06-30 | 208.0 million | 23.1 million |
2023-03-31 | 232.8 million | 21.6 million |
ATHA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -26293 | 2228 |
2023-09-30 | -24.0 million | 2.5 million |
2023-06-30 | -24.3 million | 3.1 million |
2023-03-31 | -26.4 million | 2.8 million |
ATHA Net Income
No data available :(
ATHA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 147419 | - | 1.6 million |
2023-09-30 | 172.9 million | - | 1.7 million |
2023-06-30 | 186.1 million | - | 1.8 million |
2023-03-31 | 186.0 million | - | 1.8 million |
ATHA Shares Outstanding
ATHA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 23680 | 6962 | - |
2023-09-30 | 30000 | 27.2 million | 7.8 million | - |
2023-06-30 | 33000 | 21.6 million | 10.0 million | - |
2023-03-31 | 241000 | 21.3 million | 8.5 million | - |
ATHA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | - | 244000 |
2023-06-30 | - | 297000 |
2023-03-31 | - | 287000 |
ATHA
Price: $2.18
52 week price:
Earnings Per Share: -3.09 USD
P/E Ratio: -0.98
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 290900
Market Capitalization: 75.5 million